Tekla Capital Management LLC quarter change: USA Everything Else, Unchanged
In partnership units, exchange-traded notes and anything else (listed in the US), from the quarter ended 2016-06-30 to 2016-09-30, Tekla Capital Management LLC opened 0 positions, added to 2, reduced 2, sold out of 0 and left 2 unchanged. The largest increase in value was Endo International plc (+$13,964,000); the largest decrease was Mallinckrodt plc (-$9,290,000).
- Foamix Pharmaceuticals, Ltd.: Country of operation —; Class Shares; Shares 2016-06-30 966,065; Shares 2016-09-30 966,065.
- Horizon Pharma plc: Country of operation —; Class Shares; Shares 2016-06-30 749,900; Shares 2016-09-30 749,900.
Two Form 13F-HR filings compared (SEC CIK 1300336): 2016-06-30 (filed 2016-08-12) and 2016-09-30 (filed 2016-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||